Interstitial deletion of chromosome 1q [del(1)(q24q25.3)] identified by fluorescence in situ hybridization and gene dosage analysis of apolipoprotein A-II, coagulation factor V, and antithrombin III.
We report on a 12-month-old Japanese boy with an interstitial deletion of the long-arm of chromosome 1 and meningomyelocele, hydrocephalus, anal atresia, atrial septal defect, left renal agenesis, bilateral cryptorchidism, talipes equinovarus, low birth weight, growth/developmental retardation, and many minor anomalies. By conventional GTG-banding, his karyotype was first interpreted as 46,XY,del(1)(q23q24), but it was corrected as 46,XY.ish del(1)(q24q25.3) by fluorescence in situ hybridization using 11 known cosmid clones as probes. His serum levels of apolipoprotein A-II (gene symbol: APOA2, previously assigned to 1q21-q23) and coagulation factor V (F5, 1q21-q25) were normal, while serum concentration and activity of antithrombin III (AT3, 1q23-q25.1) was low. The results indicated that localization of APOA2 and F5 are proximal to the deleted region and AT3 is located within the deletion extent in the patient.
Takano
T
T
Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan.
Yamanouchi
Y
Y
Mori
Y
Y
Kudo
S
S
Nakayama
T
T
Sugiura
M
M
Hashira
S
S
Abe
T
T
D000015:Abnormalities, Multiple / Q000175:diagnosis* / Q000235:genetics*; D000990:Antithrombin III / Q000032:analysis / Q000235:genetics*; D016633:Apolipoprotein A-II / Q000032:analysis / Q000235:genetics*; D001779:Blood Coagulation Factors / Q000032:analysis / Q000235:genetics*; D002869:Chromosome Aberrations / Q000235:genetics*; D025063:Chromosome Disorders; D002878:Chromosomes, Human, Pair 1 / Q000235:genetics*; D003360:Cosmids; D015342:DNA Probes / Q000235:genetics; D018628:Gene Dosage; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D007223:Infant; D007621:Karyotyping; D008297:Male; D017384:Sequence Deletion
D016633:Apolipoprotein A-II; D001779:Blood Coagulation Factors; D015342:DNA Probes; D000990:Antithrombin III